Illinois Municipal Retirement Fund lifted its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 12.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 124,257 shares of the biopharmaceutical company’s stock after purchasing an additional 13,921 shares during the […]
StockNews.com started coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group lowered shares of Horizon Therapeutics Public from a buy rating to a hold rating in a research […]
Vanguard Personalized Indexing Management LLC increased its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 1.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,706 shares of the biopharmaceutical company’s stock after buying an additional 261 shares during […]
StockNews.com assumed coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a research report released on Thursday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group cut shares of Horizon Therapeutics Public from a buy rating to a hold rating in a report on Friday, […]
Privium Fund Management B.V. bought a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 22,447 shares of the biopharmaceutical company’s stock, valued at approximately $2,316,000. Other institutional investors have also modified […]